Form 8-K - Current report:
SEC Accession No. 0001104659-26-013412
Filing Date
2026-02-11
Accepted
2026-02-11 16:30:18
Documents
14
Period of Report
2026-02-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tech-20260209x8k.htm   iXBRL 8-K 51315
2 EX-10.1 tech-20260209xex10d1.htm EX-10.1 134365
3 EX-99.1 tech-20260209xex99d1.htm EX-99.1 8956
  Complete submission text file 0001104659-26-013412.txt   339207

Data Files

Seq Description Document Type Size
4 EX-101.SCH tech-20260209.xsd EX-101.SCH 2655
5 EX-101.LAB tech-20260209_lab.xml EX-101.LAB 15262
6 EX-101.PRE tech-20260209_pre.xml EX-101.PRE 10901
16 EXTRACTED XBRL INSTANCE DOCUMENT tech-20260209x8k_htm.xml XML 4601
Mailing Address 614 MCKINLEY PLACE NE MINNEAPOLIS MN 55413
Business Address 614 MCKINLEY PL N E SUITE 1500 MINNEAPOLIS MN 55413 612-379-8854
BIO-TECHNE Corp (Filer) CIK: 0000842023 (see all company filings)

EIN.: 411427402 | State of Incorp.: MN | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-17272 | Film No.: 26621238
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)